One site in Nottingham, UK - built for the development and manufacture of oral, nasal, inhaled, and injectable drug products.
Years of formulation expertise across oral, nasal, pulmonary and parenteral dosage forms
GMP PROCESSING SUITES.
Average feasibility programmes fixed-scope entry point with a defined deliverable in 8 weeks.
MHRA Approved sterile manufacturing facility, designed against the revised Annex -1 guidelines.
R&D, GMP, QC and more all on one 60,000 sq.ft 60,000 sq ft facility in Nottingham, UK
Our state-of-the-art Nottingham facility houses 10 GMP manufacturing suites, quality control laboratories and dedicated analytical and formulation development laboratories with pilot plant facilities.
Trent Gateway has been specifically designed to cater to a wide range of development and manufacturing projects, offering processing of non-sterile dosage forms including solids, liquids, semi-solids, nasal and inhaled products, alongside sterile liquid and dry powder drug products.
Whether you’re in the early stages of formulation development, in need of clinical trial supplies from Phase 1 to Phase 3 or seeking niche-scale commercial manufacturing, Trent Gateway is fully equipped to fulfill your requirements with precision and excellence.
Upperton combines advanced formulation expertise, integrated development capabilities, and single-site execution to ensure speed, efficiency, and control at every stage of your drug product journey.
With 25+ years of expertise in dry powder formulations and complex dosage forms, we take full ownership of your molecule’s lifecycle from early-stage development to clinical supply and beyond.
We provide fully integrated services across every stage of drug product development:
Step inside our Trent Gateway facility with one of our subject matter experts, through our guided virtual tour. From the comfort of your laptop, explore our research laboratories, our GMP manufacturing suites, and see how take your molecule from early feasibility through to commerical on one site.